Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

September 1, 2027

Conditions

Cardiac IschemiaCesarian Section

Interventions

DRUG

Carbetocin

A uterotonic agent used for the prevention of postpartum hemorrhage in Cesarian section

Trial Locations (1)

Kingston Health Sciences Centre, Kingston

All Listed Sponsors

lead

Jordan Leitch

OTHER